Currently out of the existing stock ratings of Michael Griffin, 9 are a HOLD (50%), 9 are a BUY (50%).

Michael Griffin

Work Performance Price Targets & Ratings Chart

Analyst Michael Griffin, currently employed at EVERCORE, carries an average stock price target met ratio of 80% that have a potential upside of 11.89% achieved within 179 days. Previously, Michael Griffin worked at CITI.

Michael Griffin’s has documented 36 price targets and ratings displayed on 5 stocks.

Most recent stock forecast was given on DOC, Physicians Realty Trust at 11-May-2026.

Wall Street Analyst Michael Griffin

Analyst best performing recommendations are on JLL (JONES LANG LASALLE).
The best stock recommendation documented was for JLL (JONES LANG LASALLE) at 8/21/2024. The price target of $250 was fulfilled within 2 days with a profit of $3.44 (1.4%) receiving and performance score of 6.98.

Average potential price target upside

CBRE CBRE Group DOC Physicians Realty Trust JLL Jones Lang LaSalle PEAK Healthpeak Properties WELL Welltower

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2025

$183

$35.15 (23.77%)

$180

24 days ago
(17-Aug-2026)

0/7 (0%)

$35.04 (23.68%)

Buy Since 08-Jan-2026

$174

$26.15 (17.69%)

$175

1 months 11 days ago
(30-Jul-2026)

12/17 (70.59%)

$24.54 (16.42%)

139

Buy Since 04-Oct-2024

$175

$27.15 (18.36%)

$169

1 months 11 days ago
(30-Jul-2026)

10/14 (71.43%)

$25.54 (17.09%)

60

Buy Since 30-Jul-2026

$190

$42.15 (28.51%)

$185

1 months 11 days ago
(30-Jul-2026)

15/18 (83.33%)

$40.54 (27.12%)

63

Buy Since 19-Feb-2025

$180

$32.15 (21.75%)

$170

11 months 3 days ago
(07-Oct-2025)

4/6 (66.67%)

$27.31 (17.89%)

190

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Griffin most bullish on?

Potential upside of $0.35 has been obtained for DOC (PHYSICIANS REALTY TRUST)

What Year was the first public recommendation made by Michael Griffin?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?